Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphotoxin-alpha | 9 | 2006 | 43 | 0.720 |
Why?
|
| Transcription Factors | 4 | 2006 | 1730 | 0.320 |
Why?
|
| Thymus Gland | 3 | 2007 | 206 | 0.310 |
Why?
|
| Receptors, Tumor Necrosis Factor | 9 | 2006 | 90 | 0.270 |
Why?
|
| Collagen Type II | 1 | 2006 | 16 | 0.250 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 27 | 0.240 |
Why?
|
| Self Tolerance | 1 | 2006 | 27 | 0.240 |
Why?
|
| Immunoglobulin A | 2 | 2003 | 91 | 0.240 |
Why?
|
| Peyer's Patches | 2 | 2003 | 19 | 0.220 |
Why?
|
| Lymphotoxin beta Receptor | 9 | 2007 | 28 | 0.210 |
Why?
|
| Intestines | 2 | 2003 | 432 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2006 | 3581 | 0.180 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2016 | 382 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2006 | 705 | 0.150 |
Why?
|
| Cell Transformation, Viral | 1 | 1998 | 39 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1998 | 78 | 0.140 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 223 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 647 | 0.130 |
Why?
|
| Mice | 16 | 2009 | 12537 | 0.120 |
Why?
|
| Lymphoid Tissue | 2 | 2006 | 58 | 0.110 |
Why?
|
| Spleen | 4 | 2003 | 420 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 528 | 0.110 |
Why?
|
| Membrane Proteins | 4 | 2006 | 1275 | 0.110 |
Why?
|
| Prostate | 1 | 1998 | 423 | 0.110 |
Why?
|
| Animals | 19 | 2016 | 28889 | 0.110 |
Why?
|
| Mice, Knockout | 8 | 2006 | 2161 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2006 | 810 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 2006 | 385 | 0.100 |
Why?
|
| Cell Movement | 3 | 2006 | 816 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2006 | 712 | 0.090 |
Why?
|
| T-Lymphocytes | 5 | 2004 | 1310 | 0.090 |
Why?
|
| Psoriasis | 1 | 2014 | 254 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2006 | 830 | 0.080 |
Why?
|
| Lymph Nodes | 3 | 2003 | 554 | 0.080 |
Why?
|
| Mice, Transgenic | 8 | 2007 | 1645 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1670 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2013 | 307 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1662 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 6 | 2006 | 3491 | 0.080 |
Why?
|
| Receptors, Chemokine | 3 | 2003 | 32 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 621 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 1021 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2007 | 74 | 0.070 |
Why?
|
| CD4 Antigens | 2 | 2007 | 82 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 270 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1087 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 667 | 0.060 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2006 | 5 | 0.060 |
Why?
|
| Chemokines, CC | 2 | 2003 | 37 | 0.060 |
Why?
|
| Lymphotoxin-beta | 1 | 2006 | 6 | 0.060 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2006 | 3 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2006 | 2929 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 1087 | 0.060 |
Why?
|
| Islets of Langerhans | 2 | 2006 | 559 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1096 | 0.060 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2002 | 21 | 0.060 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 292 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 139 | 0.060 |
Why?
|
| Antigens, Ly | 1 | 2004 | 37 | 0.050 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 69 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 350 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 290 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 1739 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 61 | 0.050 |
Why?
|
| Sarcoma, Experimental | 1 | 2004 | 53 | 0.050 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 75 | 0.050 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2003 | 16 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2016 | 726 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 77 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2004 | 151 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 152 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 49 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2383 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 172 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 464 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 189 | 0.050 |
Why?
|
| Insulin | 2 | 2007 | 1190 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 22 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2003 | 281 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2003 | 465 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2004 | 1126 | 0.040 |
Why?
|
| Chemokine CCL21 | 3 | 2007 | 16 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 684 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2002 | 760 | 0.040 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 3 | 2006 | 14 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 671 | 0.040 |
Why?
|
| Chemokines | 3 | 2007 | 77 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1346 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1267 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1998 | 8 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 897 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 156 | 0.030 |
Why?
|
| Karyotyping | 1 | 1998 | 224 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2004 | 766 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 197 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2473 | 0.030 |
Why?
|
| Humans | 10 | 2016 | 95800 | 0.030 |
Why?
|
| cdc25 Phosphatases | 1 | 2016 | 19 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 279 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2012 | 687 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 2006 | 144 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2006 | 192 | 0.030 |
Why?
|
| Cetuximab | 1 | 2014 | 119 | 0.030 |
Why?
|
| Stromal Cells | 2 | 2006 | 152 | 0.030 |
Why?
|
| Leg | 1 | 2014 | 143 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2004 | 175 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2004 | 536 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 2061 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 176 | 0.020 |
Why?
|
| Keratins | 1 | 2012 | 63 | 0.020 |
Why?
|
| Urothelium | 1 | 2012 | 69 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 564 | 0.020 |
Why?
|
| Female | 6 | 2016 | 49872 | 0.020 |
Why?
|
| Gene Expression | 2 | 2004 | 1319 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 4154 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3990 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 1540 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4664 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2009 | 322 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 28208 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 229 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2007 | 110 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1166 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 517 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2009 | 325 | 0.020 |
Why?
|
| Male | 3 | 2016 | 45686 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2006 | 5 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 38 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 180 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2006 | 42 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 215 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2882 | 0.010 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2004 | 5 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 2004 | 30 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 60 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2004 | 45 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 996 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 89 | 0.010 |
Why?
|
| Oncogenes | 1 | 2004 | 99 | 0.010 |
Why?
|
| Succinimides | 1 | 2004 | 12 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 43 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2004 | 7 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2004 | 76 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 394 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2003 | 20 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2004 | 136 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2004 | 77 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2004 | 85 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 162 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 133 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 394 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 111 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 372 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 489 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 76 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 411 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7215 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 114 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 380 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 213 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 701 | 0.010 |
Why?
|
| Mucoproteins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 443 | 0.010 |
Why?
|
| Receptors, CXCR5 | 1 | 2002 | 8 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 30 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 99 | 0.010 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 157 | 0.010 |
Why?
|
| Chemokine CXCL13 | 1 | 2002 | 17 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 186 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 262 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 40 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2002 | 26 | 0.010 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2002 | 42 | 0.010 |
Why?
|
| Germinal Center | 1 | 2002 | 65 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 186 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2004 | 247 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 257 | 0.010 |
Why?
|
| B7-H1 Antigen | 1 | 2004 | 306 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1046 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 453 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 311 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 908 | 0.010 |
Why?
|
| Cysteine | 1 | 2002 | 146 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5961 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 9167 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 478 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 305 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 356 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1827 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2004 | 873 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 2575 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 871 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1192 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2536 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20848 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 595 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2089 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 563 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1756 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 1380 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5561 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 3237 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1653 | 0.010 |
Why?
|